Aminocaproic acid

Aminocaproic acid is an antifibrinolytic agent used to treat excessive bleeding by inhibiting plasminogen activation, thereby preventing fibrin degradation. It is commonly used in surgical procedures to reduce blood loss. 6-aminohexanoic acid is an epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator. Among its listed roles, it functions as a antifibrinolytic drug, a hematologic agent and a metabolite. It is an epsilon-amino acid and an omega-amino fatty acid. Functionally, it is related to hexanoic acid. It is the conjugate acid of 6-aminohexanoate. It exists as a tautomer of a 6-aminohexanoic acid zwitterion. Its therapeutic use is listed as hematologic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include 6-Aminocaproic acid, Hepin, Atsemin, Caplamin and 6-Aminohexanoic Acid. Its PubChem CID is 564.